PHARMACEUTICAL PREPARATIONS TREAT

Brand Owner (click to sort) Address Description
ALQELA Teva Pharmaceuticals USA, Inc. Building A 400 Interpace Parkway Parsippany NJ 07054 Pharmaceutical preparations to treat the vasomotor symptoms associated with menopause, vulvar and vaginal atrophy and for the prevention of osteoporosis;
AVRILLA Teva Pharmaceuticals USA, Inc. Building A 400 Interpace Parkway Parsippany NJ 07054 Pharmaceutical preparations to treat the vasomotor symptoms associated with menopause, vulvar and vaginal atrophy and for the prevention of osteoporosis;
BRONCHITOL Pharmaxis Ltd Unit 2 Australia Pharmaceutical preparations to treat and prevent diseases and disorders associated with the respiratory system; pharmaceutical preparations to treat and prevent chronic obstructive pulmonary diseases and disorders; pharmaceutical preparations for the treatment and prevention of bronchiectasis; pharmaceutical preparations for the treatment and prevention of chronic bronchitis; and pharmaceutical preparations for the treatment [and prevention] of cystic fibrosis;
DURADEX KOWA PHARMACEUTICALS AMERICA, INC. 530 Industrial Park Blvd. Montgomery AL 36116 pharmaceutical preparations to treat the symptoms of congestion and non-productive cough, cough, sinusitis, pharyngitis, bronchitis, and asthma;
DURAPHEN Proethic Laboratories P.O. Box 240067 Montgomery AL 36124 pharmaceutical preparations to treat the symptoms of congestion and non-productive cough, sinusitis, pharyngitis, bronchitis, and asthma;
ESSPLIA SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark is a coined term and has no meaning.;
KEDELIA SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;
MEONBA SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark is a coined term and has no meaning.;
PHARMAXIS Pharmaxis Ltd Unit 2 Australia Pharmaceutical preparations to treat and prevent diseases and disorders associated with the respiratory system; [ pharmaceutical preparations to treat and prevent chronic obstructive pulmonary diseases and disorders; ] pharmaceutical preparations for the treatment and prevention of bronchiectasis; [ pharmaceutical preparations for the treatment and prevention of chronic bronchitis; ] and pharmaceutical preparations for the treatment and prevention of cystic fibrosis; inhalers filled with pharmaceutical preparations to treat and prevent diseases and disorders associated with the respiratory system; [ inhalers filled with pharmaceutical preparations to treat and prevent chronic obstructive pulmonary diseases and disorders; ] inhalers filled with pharmaceutical preparations for the treatment and prevention of bronchiectasis; [ inhalers filled with pharmaceutical preparations for the treatment and prevention of chronic bronchitis; ] inhalers filled with pharmaceutical preparations for the treatment and prevention of cystic fibrosis;Color is not claimed as a feature of the mark.;Inhalers for medical purposes, sold empty; inhalers for therapeutic purposes, sold empty; [ pressurized metered dose medical inhalers, sold empty; ] dry powder inhalers for medical or therapeutic use, sold empty; medical inhalers sold empty; apparatus for administering drugs or pharmaceutical preparations by inhalation, namely, nebulizers for respiration therapy and medical apparatus for facilitating the inhalation of pharmaceutical preparations; and drug delivery apparatus, namely, drug delivery systems; replacement parts and fittings for the aforementioned goods;
REBIREN SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;
RESBREV SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark is a coined term and has no meaning.;
RHINATHIOL Synthelabo Paris France PHARMACEUTICAL PREPARATIONS TO TREAT THE RESPIRATORY SYSTEM;
RTM NEURIMMUNE HOLDING AG Wagistrasse 18 Schlieren 8952 Switzerland [ Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biocides; diagnostic preparations for medical and veterinary use; sanitary towels; Dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases ];Color is not claimed as a feature of the mark.;[ Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary purposes; chemical preparations for use in photography; biological preparations for use in cell cultures other than for medical or veterinary purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biochemicals, namely, synthetic polypeptides made from amino acids that do not derive from animals for use in diagnostic and therapeutic agents ];[ Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals ];Testing, inspection or research of pharmaceuticals [, cosmetics or foodstuffs ] ; Consultation and providing information about testing, inspection or research of pharmaceuticals [, cosmetics or foodstuffs] ; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; [ computer software design, computer programming, or maintenance of computer software; computer hardware design and development; computer software design and development ];
SIPIARE SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark is a coined term and has no meaning.;
TROGALIS SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;
VETTAV SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark is a coined term and has no meaning.;
VINSPREA SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark VINSPREA has no meaning in a foreign language.;
XAIRA SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;The mark XAIRA has no meaning in a foreign language.;
ZENHALE SCHERING CORPORATION K-6-1 M1030 2000 Galloping Hill Raod Kenilworth NJ 07033 PHARMACEUTICAL PREPARATIONS TO TREAT AND PREVENT RESPIRATORY DISEASES;ZEN HALE;The mark ZENHALE has no meaning in a foreign language.;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.